| A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes (NCT05298254) | GlaxoSmithKline | 2022-03-07 |
| A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years (NCT04762511) | GlaxoSmithKline | 2021-03-02 |
| The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata (NCT04239521) | Momentum Data | 2020-10-01 |
| Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections. (NCT04065971) | Labo'Life | 2020-03-10 |
| Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel (NCT04664127) | Nearmedic Plus LLC | 2017-10-30 |
| Tzanck Smear With Methylene Blue Stain for Herpes (NCT03178747) | Chulalongkorn University | 2017-03-07 |
| Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease (NCT02997982) | Hugo Lovheim | 2016-12-01 |
| Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test (NCT02685956) | Vela Diagnostics | 2016-04-01 |
| Open-label Study of ASP2151 in Herpes Simplex Patients (NCT02209324) | Maruho Co., Ltd. | 2013-11-01 |
| Phase III Study of ASP2151 in Herpes Simplex Patients (NCT01959295) | Maruho Co., Ltd. | 2013-08-01 |
| Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia (NCT01794897) | University of Pittsburgh | 2013-02-01 |
| Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients (NCT01602562) | GlaxoSmithKline | 2012-05-07 |
| Effectiveness of TheraNeem Lip Therapy for Herpes Simplex Labialis (NCT00985335) | Southern California University of Health Sciences | 2009-08-01 |
| Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients (NCT00973466) | Insel Gruppe AG, University Hospital Bern | 2009-05-01 |
| Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia (NCT00855309) | Wake Forest University Health Sciences | 2008-11-01 |
| HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding (NCT00530777) | University of Washington | 2008-04-01 |
| Activation of Alternative Cellular Energy (ACE) Pathway in the Therapy of Herpes Virus Infections (NCT00642785) | Institute of Progressive Medicine | 2008-01-01 |
| Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection (NCT00448227) | Novartis | 2007-10-01 |
| 30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers (NCT00587496) | National Eye Institute (NEI) | 2006-04-01 |
| Herpevac Neonatal Substudy (NCT00138320) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-08-01 |
| Episodic Acyclovir Therapy for Genital Ulcers (NCT00164424) | Centers for Disease Control and Prevention | 2005-03-01 |
| Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection (NCT00098059) | Novartis Pharmaceuticals | 2005-02-01 |
| HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons (NCT00465205) | University of Washington | 2005-01-01 |
| Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old (NCT00224484) | GlaxoSmithKline | 2004-04-07 |
| A Study of HSV Testing Among Pregnant Women (NCT00194415) | University of Washington | 2004-01-01 |
| Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine (NCT00224471) | GlaxoSmithKline | 2003-12-01 |
| A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons (NCT00161434) | University of Washington | 2003-03-01 |
| A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children (NCT00297206) | GlaxoSmithKline | 2003-01-25 |
| Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth (NCT00031447) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-08-01 |
| A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients (NCT00005663) | Glaxo Wellcome | 1999-06-01 |
| Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates (NCT00031460) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-12-01 |
| Structure of the Herpes Simplex Virus Receptor (NCT00001648) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-08-20 |
| Valaciclovir to Prevent Transmission of Herpes Simplex Virus (NCT00001649) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-08-01 |
| Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System (NCT00006132) | National Center for Research Resources (NCRR) | 1997-06-01 |
| Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease (NCT00699764) | GlaxoSmithKline | 1996-03-01 |
| Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection (NCT00004644) | National Center for Research Resources (NCRR) | 1995-02-01 |
| Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults (NCT00698893) | GlaxoSmithKline | 1992-05-01 |
| An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies (NCT00002272) | Astra USA | |
| A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients (NCT00002000) | Glaxo Wellcome | |
| Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS) (NCT00002186) | Shaman Pharmaceuticals | |
| The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood (NCT00001115) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies (NCT00002021) | Astra USA | |
| SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir (NCT00002310) | Shaman Pharmaceuticals | |
| The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children (NCT00001054) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS (NCT00002181) | Gilead Sciences | |
| A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients (NCT00002084) | Glaxo Wellcome | |
| The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU (NCT00000654) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment (NCT00002144) | Astra USA | |
| Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir (NCT00000985) | National Institute of Allergy and Infectious Diseases (NIAID) | |